Australia markets open in 54 minutes

Aptorum Group Limited (APM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.8900+0.0500 (+2.72%)
At close: 04:00PM EST
1.8950 +0.00 (+0.26%)
After hours: 04:08PM EST
Full screen
Trade prices are not sourced from all markets
Previous close1.8400
Open1.8400
Bid1.8700 x 1100
Ask1.9200 x 1400
Day's range1.8200 - 1.9700
52-week range1.8100 - 4.9400
Volume200,372
Avg. volume135,290
Market cap67.335M
Beta (5Y monthly)-0.20
PE ratio (TTM)N/A
EPS (TTM)-0.1070
Earnings date15 Sept 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est15.00
  • Business Wire

    Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 2, 2021

    NEW YORK & LONDON & PARIS, October 19, 2021--Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical stage biopharmaceutical company focused on novel technologies including the targeting of oncological diseases, announced that it will hold its 2021 annual general meeting of shareholders at Meeting Room 06, 1/F, Building 1E, Hong Kong Science Park, N.T., Hong Kong at 8:00 p.m. Hong Kong Time on December 2, 2021 (7:00 a.m. Eastern Standa

  • Business Wire

    Aptorum Group Limited Interview to Air on Bloomberg U.S.

    NEW YORK & LONDON & PARIS, October 15, 2021--Regulatory News: Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM), a clinical stage biopharmaceutical company focused on novel technologies including the targeting of oncological diseases, today announced that an interview with President Darren Lui will air on The RedChip Money Reportยฎ on Bloomberg TV Oct. 16 at 7 p.m. Eastern Time (ET).

  • Business Wire

    Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2021

    NEW YORK & LONDON & PARIS, September 15, 2021--Regulatory News: Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) ("Aptorum Group" or the "Company"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology and infectious diseases, today provided a business update and announced financial results for the six months ended June 30, 2021.